Yuli Wang

Clinical Significance of EML4-ALK Fusion Gene and Association with EGFR and KRAS Gene Mutations in 208 Chinese Patients with Non-Small Cell Lung Cancer

Ying Li, Tong Yang, Sen Wei et al. · PLoS ONE · 2013 · 116 citations · Full text

Eml4-alk Fusion Gene, Tumor Microenvironment, Eml4-alk Translocation +14

Antimycobacterial and Anti-inflammatory Mechanisms of Baicalin via Induced Autophagy in Macrophages Infected with Mycobacterium tuberculosis

Qingwen Zhang, Jinxia Sun, Yuli Wang et al. · Frontiers in Microbiology · 2017 · 111 citations · Full text

Discovery of <i>N</i>-((3<i>R</i>,4<i>R</i>)-4-Fluoro-1-(6-((3-methoxy-1-methyl-1<i>H</i>-pyrazol-4-yl)amino)-9-methyl-9<i>H</i>-purin-2-yl)pyrrolidine-3-yl)acrylamide (PF-06747775) through Structure-Based Drug Design: A High Affinity Irreversible Inhibitor Targeting Oncogenic EGFR Mutants with Selectivity over Wild-Type EGFR

Simon Planken, Douglas C. Behenna, Sajiv K. Nair et al. · Journal of Medicinal Chemistry · 2017 · 89 citations · Full text

Molecular Biology, Wild-type Egfr, Chemical Biology +21

Effects of Th17 cells and <scp>IL</scp>‐17 in the progression of cervical carcinogenesis with high‐risk human papillomavirus infection

Jisen Xue, Yuli Wang, Cheng Chen et al. · Cancer Medicine · 2017 · 59 citations · Full text

Safety of PD-1/PD-L1 Inhibitors Combined With Palliative Radiotherapy and Anti-Angiogenic Therapy in Advanced Hepatocellular Carcinoma

Liting Zhong, Dehua Wu, Weiwei Peng et al. · Frontiers in Oncology · 2021 · 47 citations · Full text